Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing proprietary new therapies to enhance the function of regulatory T cells. Its pipeline includes Treg Modifying Biologics, Allogeneic Treg-Derived Exosomes, and Autologous Treg Cell Therapy. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
8
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Coya Therapeutics Inc market cap is $69.2M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Coya Therapeutics Inc 52 week high is $6.62 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Coya Therapeutics Inc 52 week low is $2.72 as of November 21, 2026.
Coya Therapeutics Inc stock price today is $2.95.
Coya Therapeutics Inc stock price yesterday was $2.98.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Coya Therapeutics Inc's P/E ratio is -2.22.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Coya Therapeutics Inc P/B ratio is 2.0615.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Coya Therapeutics Inc 50-day moving average is $4.14.